These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16098278

  • 1. Predictors of pharmacotherapy response in anxiety disorders.
    Denys D, de Geus F.
    Curr Psychiatry Rep; 2005 Aug; 7(4):252-7. PubMed ID: 16098278
    [Abstract] [Full Text] [Related]

  • 2. Overview of diagnosis and drug treatments of anxiety disorders.
    Nutt DJ.
    CNS Spectr; 2005 Jan; 10(1):49-56. PubMed ID: 15618947
    [Abstract] [Full Text] [Related]

  • 3. Recent developments in the psychopharmacology of anxiety disorders.
    Lydiard RB, Brawman-Mintzer O, Ballenger JC.
    J Consult Clin Psychol; 1996 Aug; 64(4):660-8. PubMed ID: 8803355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP.
    J Clin Psychiatry; 1999 Aug; 60 Suppl 22():18-22. PubMed ID: 10634351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint.
    den Boer JA.
    J Clin Psychiatry; 1998 Aug; 59 Suppl 8():30-6; discussion 37-8. PubMed ID: 9707160
    [Abstract] [Full Text] [Related]

  • 8. Antidepressants and posttraumatic stress disorder.
    Meek JK, Kablinger A.
    J La State Med Soc; 1998 Oct; 150(10):487-9. PubMed ID: 9805875
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997.
    Uhlenhuth EH, Balter MB, Ban TA, Yang K.
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S393-8. PubMed ID: 10622685
    [Abstract] [Full Text] [Related]

  • 13. [Recent trends in pharmacotherapy for anxiety disorders].
    Tajima O.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):133-6. PubMed ID: 15291242
    [Abstract] [Full Text] [Related]

  • 14. WCA recommendations for the long-term treatment of panic disorder.
    Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP, World Council of Anxiety.
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):17-30. PubMed ID: 14767395
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD, Warwick J, Niehaus DJ, van der Linden G, van Heerden BB, Harvey BH, Seedat S, Stein DJ.
    BMC Psychiatry; 2004 Oct 14; 4():30. PubMed ID: 15482603
    [Abstract] [Full Text] [Related]

  • 19. Current approaches to the pharmacologic treatment of anxiety disorders.
    Sheehan DV, Sheehan KH.
    Psychopharmacol Bull; 2007 Oct 14; 40(1):98-109. PubMed ID: 17285100
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.